Familial and sporadic porphyria cutanea: two different diseases

scientific article published on October 1978

Familial and sporadic porphyria cutanea: two different diseases is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1025088004
P356DOI10.1007/BF00295407
P698PubMed publication ID730158

P2093author name stringY Nordmann
H de Verneuil
G Aitken
P2860cites workProtein measurement with the Folin phenol reagentQ20900776
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activityQ24634032
Erythrocyte metabolism. VI. Separation of erythrocyte enzymes from hemoglobinQ34021614
Porphyrin metabolism in porphyria cutanea tardaQ39621964
Analytical review enzymatic defects of hereditary porphyrias: An explanation of dominance at the molecular levelQ39714566
Porphyrins and porphyrinogen carboxy-lyase in hexachlorobenzene-induced porphyriaQ42235834
Identification of a group of tetracarboxylate porphyrins, containing one acetate and three propionate -substituents, in faeces from patients with symptomatic cutaneous hepatic porphyria and from rats with porphyria due to hexachlorobenzeneQ42730308
Porphyrin biosynthesis. VII. Porphyrinogen carboxy-lyase from avian erythrocytes. Purification and propertiesQ55061696
The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the ratQ67755745
The simultaneous separation and washing of erythrocytesQ68928283
Studies of the uroporphyrins. III. An improved method for the decarboxylation of uroporphyrinQ73399577
P433issue2
P921main subjectporphyriaQ271759
P304page(s)145-151
P577publication date1978-10-01
P1433published inHuman GeneticsQ5937167
P1476titleFamilial and sporadic porphyria cutanea: two different diseases
P478volume44

Reverse relations

cites work (P2860)
Q93614889A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron
Q28288050A zebrafish model for hepatoerythropoietic porphyria
Q53259889An editor's look-back
Q70339243Assignment of the gene for uroporphyrinogen decarboxylase to human chromosome 1 by somatic cell hybridization and specific enzyme immunoassay
Q28118865Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria
Q35960885Clinical manifestations of hepatitis C.
Q28367600Control of delta-aminolaevulinate synthase and haem oxygenase in chronic-iron-overloaded rats
Q33738781Dermatological manifestations of alcoholic cirrhosis
Q70609968Different types of porphyria cutanea tarda
Q72576225Disodium cromoglycate and the cough reflex
Q48241013Effects of chlorinated organics on intermediates in the heme pathway and on uroporphyrinogen decarboxylase
Q42070494Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria
Q35035505Effects of polyhalogenated aromatic compounds on porphyrin metabolism
Q35199862Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria
Q24539508Familial Porphyria Cutanea Tarda: Characterization of Seven Novel Uroporphyrinogen Decarboxylase Mutations and Frequency of Common Hemochromatosis Alleles
Q45954724Familial porphyria cutanea tarda in Spain: Characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation
Q62607299Genetic hemochromatosis in Italian patients with prophyria cutanea tarda: possible explanation for iron overload
Q69740094Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects
Q71465393HLA and porphyria cutanea tarda
Q57848536HOMOZYGOUS VARIEGATE PORPHYRIA
Q28367581Harderoporphyria: a variant hereditary coproporphyria
Q41924085Hepatic porphyria
Q43001747Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection.
Q45757982Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection
Q42982870Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association
Q43815439Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda
Q72468695Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?
Q53778863Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication
Q33681928Heterogeneity of familial porphyria cutanea tarda.
Q41496135Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda
Q62607290High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda
Q72553878Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda
Q44872150Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda
Q44913686Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population
Q70899822Increased inhibition of hepatic uroporphyrinogen decarboxylase by hexachlorobenzene in male rats given the oestrogenic drugs diethylstilboestrol and chlorotrianisene
Q36692232Isolation and characterization of new porphyrin metabolites in human porphyria cutanea tarda and in rats treated with hexachlorobenzene by HPTLC, HPLC and liquid secondary ion mass spectrometry
Q36686039Isolation, sequencing and expression of cDNA sequences encoding uroporphyrinogen decarboxylase from tobacco and barley.
Q28576673Mechanism of hexachlorobenzene-induced porphyria in rats. Effect of phenobarbitone pretreatment
Q54788604Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: Characterization of four novel mutations
Q34520576Molecular analysis of uroporphyrinogen decarboxylase deficiency in a family with two cases of hepatoerythropoietic porphyria
Q34649898Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene
Q36267789Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias
Q70072492Porphyria cutanea tarda and HLA-linked hemochromatosis
Q43038650Porphyria cutanea tarda and antibodies to hepatitis C virus.
Q34392355Porphyria cutanea tarda and haemochromatosis: a family study
Q72511186Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study
Q42574912Porphyria cutanea tarda and hepatitis C virus infection in a patient with acute liver failure.
Q49294257Porphyria cutanea tarda during maintenance haemodialysis
Q39729523Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases
Q34097888Porphyria cutanea tarda.
Q70027904Porphyria. Basic science aspects
Q37305931Porphyrias and porphyrins
Q39696618Porphyrinurias and occupational disease
Q71142642Prenatal exclusion of congenital erythropoietic porphyria (Günther's disease) in a fetus at risk
Q35217843Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis.
Q41963947Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver
Q40150902Recent advances in the identification of enzyme deficiencies in the porphyrias
Q70069371Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda
Q42623529Systemic abnormalities in liver disease
Q40178065The Biochemical Diagnosis of the Porphyrias
Q50986042The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland
Q28579667The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage
Q70871968The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron
Q41985126The effects in vivo of mutationally modified uroporphyrinogen decarboxylase in different hem12 mutants of baker's yeast (Saccharomyces cerevisiae).
Q69743227The effects of ethanol, estrogen, and hexachlorobenzene on the activities of hepatic delta-aminolevulinate synthetase, delta-aminolevulinate dehydratase, and uroporphyrinogen decarboxylase in male rats
Q45056835The genetic basis of porphyria cutanea tarda
Q72910854The porphyrias
Q40943275The porphyrias: a brief overview based on 25 years of experience (1969-1994) by the Department of Dermatology of the Hospital Clinic and Faculty of Medicine of Barcelona, Spain
Q43522902The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection
Q72922436The role of possible membrane damage in porphyria cutanea tarda: A spin label study of rat liver cell membranes
Q41914010Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine
Q71427038Uroporphyria development in cultured chick embryo fibroblasts long-term treated with chloramphenicol and ethidium bromide
Q40433950Uroporphyrinogen decarboxylase
Q69509293[Anesthesia and hepatic porphyria]

Search more.